Phil Parkinson must turn his attention back to cup action on Tuesday night though as Wrexham take on Port Vale in the EFL ...

Wrexham are back in action on Tuesday night as Phil Parkinson prepares his side for EFL Trophy action against League Two side ...

Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

From this you can see that Virtually Parkinson was never intended to replace a host but to be an experiment in interaction ...

Midway through first term as L.A. County sheriff, Robert Luna told The Times that speculation he might step down is "not true ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

When Hurricane Milton caused the rare cancelation of the American Health Care Association/National Center for Assisted Living ...

KinCon biolabs, a spin-off from the University of Innsbruck, is expanding its patented platform technology to support ...

The Parkinson’s Group, Glenvista Chapter held their year-end function on November 9 at the Renaissance Retirement Village. The function was a great success, a large spread as well as a great turnout ...